LUMISENSE
LIVE

Serial Number

79367837

Owner

Trince, besloten vennootschap

Attorney

Clifford D Hyra

Filing Date

Feb 14, 2023

Add to watchlist:

No watchlists yet
View on USPTO

LUMISENSE Trademark

Serial Number: 79367837 • Registration: 7452179

LUMISENSE is a trademark filed by Trince, besloten vennootschap on February 14, 2023. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Trince, besloten vennootschap (3 trademarks)

Ottergemsesteenweg-Zuid 731

Entity Type: 99

Trademark Details

Filing Date

February 14, 2023

Registration Date

July 23, 2024

Published for Opposition

May 7, 2024

Goods & Services

Cells for medical or clinical use; personalized autologous or allogeneic cell-based therapies in the nature of cells for medical use; biological preparations for use in cell cultures for medical applications; pharmaceutical preparations and substances for the treatment of genetic diseases in the nature of single-gene disorders, immunological diseases and cancer; pharmaceutical preparations and substances for applications in tissue engineering and regenerative medicine for cell transplantation, stem cell therapy and gene therapy; reagents for medical use; biological reagents for medical use; diagnostic reagents for medical use; reagents for use in medical genetic testing; stem cells for medical purposes; engineered medicinal cell-based products, cell lines and biomolecules, namely, genetically engineered cells for medical use; medical reagents contained in a cartridge for medical diagnostic use

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Feb 1, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jan 15, 2025 FICS
FINAL DISPOSITION PROCESSED
Jan 15, 2025 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 23, 2024 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 23, 2024 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 23, 2024 R.PR
NOTIFICATION PROCESSED BY IB
May 8, 2024 GPNX
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 7, 2024 NPUB
PUBLISHED FOR OPPOSITION
May 7, 2024 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 17, 2024 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 17, 2024 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Apr 17, 2024 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 3, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 2, 2024 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Dec 21, 2023 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 21, 2023 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Dec 21, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 21, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Dec 21, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 21, 2023 COAR
REFUSAL PROCESSED BY IB
Dec 4, 2023 RFNP
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 16, 2023 RFCS
REFUSAL PROCESSED BY MPU
Nov 16, 2023 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Nov 16, 2023 RFCR
NON-FINAL ACTION WRITTEN
Nov 15, 2023 CNRT
ASSIGNED TO EXAMINER
Nov 14, 2023 DOCK
NEW REPRESENTATIVE AT IB RECEIVED
Jun 4, 2023 NREP
APPLICATION FILING RECEIPT MAILED
Apr 25, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Apr 21, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Apr 20, 2023 REPR